Cargando…

Impaired Expression of Focal Adhesion Kinase in Mesenchymal Stromal Cells from Low-Risk Myelodysplastic Syndrome Patients

The pathogenic role of mesenchymal stromal cells (MSCs) in myelodysplastic syndromes (MDS) development and progression has been investigated by numerous studies, yet, it remains controversial in some aspects (1, 2). In the present study, we found distinct features of MSCs from low-risk (LR)-MDS stro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yuenv, Aanei, Carmen Mariana, Kesr, Sanae, Picot, Tiphanie, Guyotat, Denis, Campos Catafal, Lydia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551509/
https://www.ncbi.nlm.nih.gov/pubmed/28848706
http://dx.doi.org/10.3389/fonc.2017.00164
_version_ 1783256315333705728
author Wu, Yuenv
Aanei, Carmen Mariana
Kesr, Sanae
Picot, Tiphanie
Guyotat, Denis
Campos Catafal, Lydia
author_facet Wu, Yuenv
Aanei, Carmen Mariana
Kesr, Sanae
Picot, Tiphanie
Guyotat, Denis
Campos Catafal, Lydia
author_sort Wu, Yuenv
collection PubMed
description The pathogenic role of mesenchymal stromal cells (MSCs) in myelodysplastic syndromes (MDS) development and progression has been investigated by numerous studies, yet, it remains controversial in some aspects (1, 2). In the present study, we found distinct features of MSCs from low-risk (LR)-MDS stromal microenvironment as compared to those from healthy subjects. At the molecular level, focal adhesion kinase, a key tyrosine kinase in control of cell proliferation, survival, and adhesion process, was found profoundly suppressed in expression and activation in LR-MDS MSC. At a functional level, LR-MDS MSCs showed impaired growth and clonogenic capacity, which were independent of cellular senescence and apoptosis. The pro-adipogenic differentiation and attenuated osteogenic capacity along with reduced SDF-1 expression could be involved in creating an unfavorable microenvironment for hematopoiesis. In conclusion, our experiments support the theory that the stromal microenvironment is fundamentally altered in LR-MDS, and these preliminary data offer a new perspective on LR-MDS pathophysiology.
format Online
Article
Text
id pubmed-5551509
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-55515092017-08-28 Impaired Expression of Focal Adhesion Kinase in Mesenchymal Stromal Cells from Low-Risk Myelodysplastic Syndrome Patients Wu, Yuenv Aanei, Carmen Mariana Kesr, Sanae Picot, Tiphanie Guyotat, Denis Campos Catafal, Lydia Front Oncol Oncology The pathogenic role of mesenchymal stromal cells (MSCs) in myelodysplastic syndromes (MDS) development and progression has been investigated by numerous studies, yet, it remains controversial in some aspects (1, 2). In the present study, we found distinct features of MSCs from low-risk (LR)-MDS stromal microenvironment as compared to those from healthy subjects. At the molecular level, focal adhesion kinase, a key tyrosine kinase in control of cell proliferation, survival, and adhesion process, was found profoundly suppressed in expression and activation in LR-MDS MSC. At a functional level, LR-MDS MSCs showed impaired growth and clonogenic capacity, which were independent of cellular senescence and apoptosis. The pro-adipogenic differentiation and attenuated osteogenic capacity along with reduced SDF-1 expression could be involved in creating an unfavorable microenvironment for hematopoiesis. In conclusion, our experiments support the theory that the stromal microenvironment is fundamentally altered in LR-MDS, and these preliminary data offer a new perspective on LR-MDS pathophysiology. Frontiers Media S.A. 2017-08-08 /pmc/articles/PMC5551509/ /pubmed/28848706 http://dx.doi.org/10.3389/fonc.2017.00164 Text en Copyright © 2017 Wu, Aanei, Kesr, Picot, Guyotat and Campos Catafal. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Wu, Yuenv
Aanei, Carmen Mariana
Kesr, Sanae
Picot, Tiphanie
Guyotat, Denis
Campos Catafal, Lydia
Impaired Expression of Focal Adhesion Kinase in Mesenchymal Stromal Cells from Low-Risk Myelodysplastic Syndrome Patients
title Impaired Expression of Focal Adhesion Kinase in Mesenchymal Stromal Cells from Low-Risk Myelodysplastic Syndrome Patients
title_full Impaired Expression of Focal Adhesion Kinase in Mesenchymal Stromal Cells from Low-Risk Myelodysplastic Syndrome Patients
title_fullStr Impaired Expression of Focal Adhesion Kinase in Mesenchymal Stromal Cells from Low-Risk Myelodysplastic Syndrome Patients
title_full_unstemmed Impaired Expression of Focal Adhesion Kinase in Mesenchymal Stromal Cells from Low-Risk Myelodysplastic Syndrome Patients
title_short Impaired Expression of Focal Adhesion Kinase in Mesenchymal Stromal Cells from Low-Risk Myelodysplastic Syndrome Patients
title_sort impaired expression of focal adhesion kinase in mesenchymal stromal cells from low-risk myelodysplastic syndrome patients
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551509/
https://www.ncbi.nlm.nih.gov/pubmed/28848706
http://dx.doi.org/10.3389/fonc.2017.00164
work_keys_str_mv AT wuyuenv impairedexpressionoffocaladhesionkinaseinmesenchymalstromalcellsfromlowriskmyelodysplasticsyndromepatients
AT aaneicarmenmariana impairedexpressionoffocaladhesionkinaseinmesenchymalstromalcellsfromlowriskmyelodysplasticsyndromepatients
AT kesrsanae impairedexpressionoffocaladhesionkinaseinmesenchymalstromalcellsfromlowriskmyelodysplasticsyndromepatients
AT picottiphanie impairedexpressionoffocaladhesionkinaseinmesenchymalstromalcellsfromlowriskmyelodysplasticsyndromepatients
AT guyotatdenis impairedexpressionoffocaladhesionkinaseinmesenchymalstromalcellsfromlowriskmyelodysplasticsyndromepatients
AT camposcatafallydia impairedexpressionoffocaladhesionkinaseinmesenchymalstromalcellsfromlowriskmyelodysplasticsyndromepatients